Prenetics Global Ltd (PRE) USD0.0001
Sell:$4.50Buy:$5.47
$0.07
(1.38%)
- This stock can be held in a
Stocks and Shares ISA$0.07
(1.38%)$0.07
(1.38%)Company Information
About this company
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Key people
Key facts
- EPICPRE
- LocationHong Kong
- SectorHealthcare
- IndustryHealthcare Facilities
- ISINKYG722451229
- Market cap$55.28m
- Employees320
- Shares in issue10.64m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.